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C11-BODIPYThe membranes of healthy lymphocytes normally resist hydrolysis by secretory phospholipase A2. However,
they become susceptible during the process of apoptosis. Previous experiments have demonstrated the im-
portance of certain physical changes to the membrane during cell death such as a reduction in membrane
lipid order and exposure of phosphatidylserine on the membrane surface. Nevertheless, those investigations
also showed that at least one additional factor was required for rapid hydrolysis by the human group IIa
phospholipase isozyme. This study was designed to test the possibility that oxidation of membrane lipids
is the additional factor. Flow cytometry and confocal microscopy with a ﬂuorescent probe of oxidative poten-
tial suggested that oxidation of the plasma membrane occurs during apoptosis stimulated by thapsigargin.
When oxidative potential was high, the activity of human group IIa secretory phospholipase A2 was enhanced
30- to 100-fold compared to that observed with conditions sufﬁcient for maximal hydrolysis by other secre-
tory phospholipase A2 isoforms. Direct oxidation of cell membranes with either of two oxidizing
agents also stimulated hydrolysis by secretory phospholipase A2. Both oxidizers caused externalization of
phosphatidylserine, but a change in lipid order did not always occur. These results demonstrated that mem-
brane oxidation strongly stimulates human group IIa secretory phospholipase A2 activity toward apoptotic
cells. Interestingly, the change in membrane order, previously thought to be imperative for high rates of hy-
drolysis, was not required when membrane lipids were oxidized. Whether phosphatidylserine exposure is
still necessary with oxidation remains unresolved since the two events could not be deconvoluted.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Recently, we have focused on the relationship between apoptosis
and the activity of various isoforms of sPLA2. Numerous studies
have identiﬁed two physical changes as being relevant to the action
of sPLA2 during cell death: 1) an increase in the presence of anionic
phospholipids (generally phosphatidylserine, PS) in the outer leaﬂet
of the membrane [1–7] and 2) a decrease in membrane lipid order
reﬂecting diminished strength of interactions among adjacent phos-
pholipids [5–11]. In addition, studies with calcium ionophore-
stimulated death indicated that a third membrane alteration must
be essential for the human group IIa isoform (hGIIa) of the enzyme
[7,12]. Even though ionophore-stimulated calcium uptake caused im-
mediate full exposure of PS and maximal reduction in lipid order,
hGIIa sPLA2 did not hydrolyze the cell membrane. These observations
strongly contrasted the response of the enzyme to artiﬁcial mem-
branes composed entirely of anionic phospholipids [3,4,7,12–14]. Fur-
thermore, a different isoform, hGX, hydrolyzed ionophore-treatedg University, Provo, UT 84602,
l rights reserved.cells at a greater rate than apoptotic cells and appeared not to require
a third factor [7].
A recent publication reported that some apoptotic inducers pro-
duce a subpopulation of cells with slight permeability to propidium
iodide [12]. This modest permeability correlated with increased sus-
ceptibility to the hGIIa isozyme. That study suggested that plasma
membrane oxidation could be a candidate for the third membrane al-
teration mentioned above [12]. This hypothesis is supported by three
observations. First, cytochrome c release during apoptosis causes lipid
oxidation [15–20]. Second, lipid oxidation enhances the permeability
of artiﬁcial bilayers [19,21–23]. Third, membranes containing oxi-
dized lipids are more susceptible to hydrolysis by the hGIIa isoform
of sPLA2 [24–28].
We have therefore tested the hypothesis that membrane oxidation
is the third factor required for amembrane to become susceptible to hy-
drolysis by hGIIa sPLA2. Accordingly, we assayed lipid oxidation poten-
tial of S49 lymphoma cells during death triggered by thapsigargin (TG),
an inhibitor of the endoplasmic reticulum Ca2+ ATPase that causes ER
stress [29–31]. Activity of hGIIa sPLA2 was then assayed to determine
if susceptibility correlated with membrane oxidation. Cell membranes
were then directly oxidized using tert-butyl hydroperoxide (TBHP) or
2,2′-azobis-2-methyl-propanimidamide, dihydrochloride (AAPH, a
Fig. 1. Plasma membrane oxidation during TG-induced apoptosis. Lipid oxidative po-
tential of the membrane was assessed by confocal microscopy (Panels A, B) and ﬂow
cytometry (Panel C) using C11-BODIPY581/591. Probes ﬂuorescing green represent
those that have been oxidized. Panel A: control cells. Panel B: cells treated with
thapsigargin for 4.5 h.
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determined. Externalization of PS and lipid order were also assessed to
establishwhich of thesemembrane changes is necessary for hGIIa sPLA2
activity.
2. Materials and methods
2.1. Reagents
The hGIIa and snake venom (Agkistrodon piscivorus piscivorus)
isoforms of sPLA2 were isolated and prepared as described [32,33].
Thapsigargin and NecroX-5™ were obtained from Enzo Life
Sciences (Plymouth Meeting, PA). Acrylodan-labeled fatty acid-binding
protein (ADIFAB), merocyanine 540 (MC540), 6-palmitoyl-2-[[2-
(trimethylammonio)ethyl]methylamino]naphthalene chloride (Patman),
1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene (TMA-
DPH), and 4,4-diﬂuoro-5-(4-phenyl-1,3-butadienyl)-4-bora-3a,4a-
diaza-s-indacene-3-undecanoic acid (C11-BODIPY581/591) were
purchased from subsidiaries of Life Technologies (Grand Island, NY).
The oxidizers TBHP and AAPH were purchased from Sigma-Aldrich
(St. Louis, MO) and Cayman Chemical (Ann Arbor, MI), respectively.
Trolox was also obtained from Cayman Chemical.
2.2. General
S49 murine lymphoma cells were cultured in suspension in
Dulbecco's Modiﬁed Eagle Medium containing 10% heat-inactivated
horse serum as described (10% CO2, 37 °C, [34]). Cells were harvested,
washed, and resuspended in a balanced salt buffer (134 mM NaCl,
6.2 mM KCl, 1.6 mM CaCl2, 1.2 mM MgCl2, 18 mM HEPES, 13.6 mM
glucose, pH 7.4 at 37 °C) to a density of 0.5–2×106/ml prior to experi-
mentation. Treatment with TG (5 μM), AAPH (3 mM, dissolved in
culturemedium fresh immediately prior to each experiment), or associ-
ated controls was done in culture media. For experiments involving
TBHP (0.4 mM), cells were treated after harvesting. All experiments
were performed at 37 °C. In all quantitative representations of the
data, error bars represent the range or SE (n>2).
2.3. Confocal microscopy
Images were collected on an Olympus FluoView FV 300 confocal
laser scanning microscope using a 60× oil immersion objective lens.
Cells were stained with C11-BODIPY581/591 (2 μM ﬁnal) for at least
1 h in culture prior to treatment with TG or an oxidizer. Two different
lasers and emission ﬁlter sets were used concurrently to excite and
collect ﬂuorescence from both oxidized (488 nm argon laser,
505–525 nm bandpass emission ﬁlter, green color in images)
and non-oxidized probes (543 nm helium-neon laser, 560–660 nm
bandpass emission ﬁlter, red color in images). Experimental temper-
ature was maintained throughout imaging using a heated stage.
2.4. Flow cytometry
When assaying oxidative potential, cells were incubated with
C11-BODIPY581/591 as described above. To assay PS externalization,
cells were treated with TG, oxidizing agents, or control vehicle as de-
scribed above and then stained with annexin V Alexa Fluor® 488 con-
jugate for 15 min after cell harvesting. Samples were processed in a
BD FACSCanto ﬂow cytometer (BD Biosciences, San Jose, CA) with
an argon excitation laser (488 nm) and an emission bandpass ﬁlter
(515–545 nm).
For C11-BODIPY581/591, ﬂuorescence histograms of control sample
ﬂuorescence were ﬁt to a Gaussian curve. Fluorescence histograms of
treated samples were then ﬁt with two Gaussian curves with one
constrained to the mean and standard deviation of the corresponding
control. The area under the second Gaussian curve normalized to thetotal ﬂuorescence was reported as the percent of the population
staining positive for oxidized C11-BODIPY581/591. Data from annexin
V samples were gated according to the intensity proﬁle of samples
Fig. 2. Membrane hydrolysis by hGIIa sPLA2 during TG-stimulated apoptosis. Panel A: time
proﬁle of membrane hydrolysis after addition of hGIIa sPLA2 (dotted line) in cell samples
treated 3 h (black) or 5 h (gray) with TG. Panel B: initial rates of hydrolysis (gray bars)
were calculated from data like those in Panel A. The error was ≤0.0001 GPADIFAB units
(n=2–4), which is difﬁcult to discern visually in the graph. Overlays show timing of PS ex-
posure (dashed curve) and membrane oxidation (solid curve) assayed by ﬂow cytometry
(AlexaFluor-labeled annexin V and C11-BODIPY581/591, respectively).
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exposure.2.5. Spectroscopy
Fluorescence spectroscopy was performed using a Fluoromax
(Horiba Jobin Yvon, Edison, NJ) photon-counting spectroﬂuorometer
or a PC-1 (ISS, Champaign, IL) photon-counting spectroﬂuorometer
for anisotropy measurements. Cell sample homogeneity was ensured
by continuous stirring with a magnetic stir bar, and temperature was
held constant by a circulating water bath. Bandpass was 16 nm for
anisotropy measurements and 4 nm for all others.
Membrane hydrolysis catalyzed by sPLA2 was assayed by ADIFAB
ﬂuorescence as described [7,12]. The amount of fatty acid released
was quantiﬁed by comparing ADIFAB ﬂuorescence emission (65 nM
ﬁnal; excitation=390 nm) at 432 and 505 nm and calculating the
generalized polarization (GPADIFAB) [12]. The maximal hydrolysis
rate was estimated by ﬁtting the data to an arbitrary function (sum
of exponentials) by nonlinear regression and calculating the ﬁrst de-
rivative of the resulting curve.
Membrane order was inferred from ﬂuorescence measurements
with TMA-DPH, Patman, and MC540. For TMA-DPH steady-state an-
isotropy, ﬂuorescence was collected with different conﬁgurations of
excitation (350 nm) and emission (452 nm) polarizers in the vertical
and horizontal positions after 10 min equilibration of cells with the
probe (250 nM ﬁnal). The anisotropy was then calculated from the
ﬂuorescence intensity and corrected for differential transmission
and detection at the two polarizer positions [11]. Patman (250 nM
ﬁnal) ﬂuorescence intensity was assayed as a function of time with
excitation at 350 nm and emission at 435 and 500 nm. Spectral
changes were quantiﬁed by calculating the Patman generalized polar-
ization (GP) [11]. The intensity of MC540 ﬂuorescence (170 nM ﬁnal)
was assayed at 585 nm (excitation=540 nm) as described [35,36].3. Results and discussion
A ﬂuorescent lipid analog, C11-BODIPY581/591, was used to assess
the lipid oxidative potential of cell membranes after treatment with
TG [37]. As shown in Fig. 1, confocal microscopy revealed that
C11-BODIPY581/591 became oxidized (green) after TG treatment
(Panel B) compared to control cells (Panel A). The percentage of the
cell population that contained oxidized C11-BODIPY581/591 was quan-
tiﬁed using ﬂow cytometry after different lengths of incubation with
TG to determine the temporal onset of lipid oxidation (Panel C). Max-
imum oxidation did not occur until after 4.5 h with TG.
Previous reports demonstrated that the activity of the hGIIa isozyme
is enhanced during apoptosis, including that stimulated by TG [7,12].
However, even though the enhancement was signiﬁcant compared to
the undetectable hydrolysis of quiescent cells, it was dwarfed by that cat-
alyzed by other sPLA2 isozymes [7,12]. Compared to a standard for full ac-
tivity (hydrolysis of dipalmitoylphosphatidylglycerol liposomes), human
groups V and X isozymes were 31±2 and 58±7% of that maximum
when hGIIa was only 0.46±0.09% [7,12]. In the case of TG-induced apo-
ptosis, these measurements were obtained at 3-h treatment with TG, a
time point at which the activity of the other sPLA2 isozymes toward ap-
optotic cells is maximal [12]. However, Fig. 1 shows that oxidation is a
later event in TG-induced death. Therefore, to explore the possible role
of oxidation, hGIIa sPLA2 activity was compared between 3 and 5 h incu-
bation with TG (Fig. 2A). The initial hydrolysis rates frommultiple repli-
cates are represented as gray bars in Fig. 2B and overlaid with PS
externalization (dashed curve; data from [11]) and C11-BODIPY581/591
oxidation (solid curve; data from Fig. 1C). Although signiﬁcant activity
was detectable at 3 h, it increased 30-fold at 5 h.
To further validate the possibility that membrane oxidation is the
key factor required for this isozyme, chemical oxidizing agents were
used to directly cause lipid oxidation (Fig. 3). Confocal microscopy
with C11-BODIPY581/591 was used to verify that the plasma mem-
brane becomes oxidized after treatment with TBHP (60 min; Panel
B compared to Panel A) and AAPH (15 h; Panel D compared to
Panel C). In both cases, oxidation was widespread among the cells.
In contrast, treatment of the cells with ionomycin, which renders
them fully susceptible to some sPLA2 isozymes, such as human
group X, but not hGIIa [7], did not result in appreciable oxidation
(Panels E and F). Fig. 4A demonstrates that the two agents that caused
membrane oxidation also stimulated hydrolysis by hGIIa. In fact, the
rates were substantially higher than that observed with 5 h TG
(2.5–3-fold greater). Control experiments with TBHP in the presence
of antioxidants (trolox or NecroX-5™) demonstrated that the results
depended on oxidation rather than artifactual effects of the agent.
As mentioned above, decreased lipid order and exposure of
phosphatidylserine have been linked to high sPLA2 activity. Therefore,
these two membrane changes were assayed after treatment with
TBHP and AAPH. Lipid order was assessed with three different ﬂuo-
rescent probes: MC540, TMA-DPH, and Patman. As shown in Fig. 4B,
TBHP treatment caused an increase in MC540 ﬂuorescence compara-
ble to that caused by TG [11]. This effect has been shown previously to
reﬂect a decrease in lipid packing density in the plasma membrane
pursuant to a reduction in bilayer order [35,36,38]. Likewise, TBHP
caused a decrease in the value of TMA-DPH anisotropy similar to
the result with TG (Fig. 4C). In contrast, effects of TBHP on Patman
ﬂuorescence were less than half that observed with 5 h TG treatment
(Fig. 4D). The results with AAPH differed substantially from those
with TBHP. Although it was equal or better at promoting hydrolysis
compared to TBHP, it was much weaker at promoting changes in
membrane order detected by Patman or MC540 (black bars, Fig. 4B
and D). Interestingly, TMA-DPH anisotropy was altered by AAPH to
a level comparable to that induced by the other agents (Fig. 4C). Ex-
ternalization of PS (annexin V binding) was assayed by ﬂow cytome-
try. Both TBHP and AAPH induced PS exposure, as expected [39,40],
although the effects tended to be smaller and more variable than
A B C
D E F
Fig. 3. Confocal microscopy images of membrane oxidation in cells treated with TBHP, AAPH, or ionomycin. See Fig. 1 for ﬂuorescence details. Panels A, C, and E: relevant vehicle
controls matched with the treatment samples in Panels B, D, and F. Panel B: 60 min TBHP; Panel D: 15 h AAPH; Panel F: 9 min ionomycin.
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ticoid (TBHP: 37.7±9.6% increase in annexin-positive cells, AAPH:
39.0±13.2% increase, TG: 85.6±0.7% increase [11], glucocorticoid:
83.7% increase [35]).Fig. 4. Effects of TBHP and AAPH on hydrolysis by sPLA2 and on membrane order. Panel A: ini
or 5 h with TG, at least 21 min with TBHP, or at least 14 h with AAPH. Parallel samples were
GP (Panel D). Differences among treatment groups were signiﬁcant by one-way analysis ofWe concluded, based on these results, that oxidation is likely to be
the source of the “third membrane alteration” postulated previously
[12] as described in the Introduction. However, the data of Fig. 4B–
D indicate that all three alterations are not simultaneously requiredtial hydrolysis rates were calculated from data like those in Fig. 2A for samples treated 3
assessed for MC540 ﬂuorescence (Panel B), TMA-DPH anisotropy (Panel C), or Patman
variance (pb0.016) for Panels A, B, and D (n=2–8 per group).
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ly, the reduction in membrane order, thought previously to be critical,
was not necessary when oxidation had occurred. To test whether this
effect was conﬁned to hGIIa, we repeated the hydrolysis experiments
of Fig. 4A toward AAPH-treated cells with a generic snake venom
sPLA2 for which the role of membrane order is prominent and well
established [7,35,36,41–43]. Treatment with AAPH stimulated hydro-
lysis by the snake venom isozyme to an extent similar to that ob-
served when membrane order changes and PS exposure have
occurred in the absence of oxidation (110±23% of the activity ob-
served at 3, 5 h TG treatment reported in [11], n=4). This result sug-
gests that oxidation of the membrane can replace the need for
alterations of membrane order by promoting the same step in the hy-
drolysis reaction scheme. In fact, the data for hGIIa argue that oxida-
tion is more effective. A recent study demonstrated quantitatively
that the change in membrane order is likely to enhance hydrolysis
by increasing the probability that individual phospholipids in the bi-
layer can spontaneously protrude to an extent sufﬁcient to enter the
active site of adsorbed sPLA2 [11]. Although oxidation of membrane
lipids does not necessarily alter overall membrane physical properties
in the same way as observed during apoptosis (compare patterns of
TBHP and AAPH with TG results in Fig. 4B–D), other structural analy-
ses have identiﬁed an alternative hypothesis that may explain
how this chemical alteration could increase phospholipase activity
[19,44,45]. This “lipid whisker hypothesis” describes a dominant con-
formation of oxidized phospholipids in which the altered fatty acid
tail extends out from the membrane surface into the aqueous phase.
Thus, the lipid is positioned in the bilayer with one tail immersed nor-
mally and the other extended in the opposite direction. This altered
conformation might allow the entry of the extended acyl chain into
the enzyme active site without the need for vertical protrusion of
the phospholipid [19,46]. Although the data of this paper do not
prove that idea, they are consistent with it. Future experiments iden-
tifying directly the speciﬁc substrates for sPLA2 during apoptosis will
be needed to validate this idea further.
The ability of oxidation to replace the need for a change in mem-
brane order begs the question of whether exposure of anionic lipids
such as PS on the exterior of the cell is still necessary for hGIIa after
oxidation. This question cannot be answered deﬁnitively with the
data obtained here since all treatments that produced oxidation also
caused exposure of PS. This result may corroborate earlier ﬁndings
that oxidation of phospholipids creates a means of both enzymatic
and non-enzymatic transfer of PS to the outer leaﬂet of the cell mem-
brane [47,48]. Nevertheless, it is well established that the residence
time of hGIIa on a membrane surface is extremely short unless anion-
ic lipids are also present. Measurements of adsorption of hGIIa sPLA2
to artiﬁcial membranes by a centrifugation assay revealed that the ap-
parent association constant increased from undetectable for a 10% PS/
phosphatidylcholine mixture to 5000 M−1 in a 30% mixture [4]. Like-
wise, the rate of hydrolysis of a pure anionic membrane is 300-fold
greater than that observed toward a zwitterionic bilayer [4]. The rea-
son for this signiﬁcant effect is clear upon considering the structure of
the interfacial binding surface of hGIIa. It is highly enriched in cationic
residues and devoid of trp residues present on the interfacial adsorp-
tion surface of other sPLA2 isozymes that act more effectively on zwit-
terionic membranes [32,49–52].
Some of the products of phospholipid oxidation are also anionic,
with carboxylic acids on fatty acid chains broken by the introduction
of peroxides. Based on the lipid whisker hypothesis, these carboxylic
acids would be exposed on the membrane surface where they could
interact with sPLA2. Thus, it seems plausible that oxidation would as-
sist adsorption of the enzyme directly in addition to its effect to en-
hance the ability of affected phospholipids to enter the active site of
sPLA2. Nonetheless, it is likely that this contribution of lipid oxidation
would be relatively small since many oxidation products are
not charged. Thus far, to the authors' knowledge, no evidence forimproved adsorption of hGIIa to bilayers composed of oxidized lipids
has been reported, and experiments to test that idea are therefore need-
ed. Regardless, the adsorption potential of hGIIa is still not fully realized
with mammalian cells even with the combined effects of PS exposure
and lipid oxidation. For example, we found that hGIIa hydrolyzes lipo-
somes of pure anionic phospholipid (dipalmitoylphosphatidylglycerol)
analogous to bacterial membranes at a 4-fold higher rate than oxidized
mammalian cell membranes (comparing average of TBHP and AAPH
data of this paper to the standards reported by us in previous studies
[7,12]).
Much of what is known about phospholipid oxidation and sPLA2
comes from studies of lipoproteins. The heightened action of hGIIa to-
ward oxidized lipoproteins has been proposed as a major action of the
isozyme with signiﬁcant implications for the pathology of atheroscle-
rosis [27,53,54]. The potential for similar responsiveness of hGIIa to-
ward cell membranes that have become oxidized during apoptosis
or other traumatic events had not received comparable attention.
Here we show that that potential is real and merits further investiga-
tion. Although the focus here was on the hGIIa isozyme, preliminary
results with snake venom sPLA2 raise the possibility that other iso-
zymes may respond similarly to oxidation. At least some of these
other isozymes, such as group X and group V, respond to other mem-
brane changes such as decreased lipid order and PS exposure to a
greater extent than hGIIa in the absence of oxidation [7]. Thus, differ-
ent forms of cell damage as well as different moments along the time
course of programmed cell death will capacitate different sPLA2 iso-
zymes depending on the types and relative amounts of membrane
changes occurring. For example, early in some forms of apoptosis,
the membrane becomes susceptible to group X sPLA2 prior to signiﬁ-
cant PS exposure and oxidation [7,12]. As shown in this study, hGIIa
will attack those cells later in the process when oxidation initiated
in the mitochondria has spread to the plasma membrane. Physiolog-
ically, this secondary attack by hGIIa should be forestalled by phago-
cytosis of apoptotic cells activated by exposure of oxidized PS [55,56].
Nevertheless, in other conditions in which membrane oxidation is
prevalent, such as certain neurodegenerative diseases [57,58], the ac-
tion of hGIIa and other sPLA2 isozymes may be substantial, leading to
death of affected cells and untoward release of proinﬂammatory fatty
acids and lysophospholipids.
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